-
Mashup Score: 0Utilization of COVID-19 Treatments and Clinical Outcomes among Patients with Cancer: A COVID-19 and Cancer Consortium (CCC19) Cohort Study - 3 year(s) ago
Among 2,186 U.S. adults with invasive cancer and laboratory-confirmed SARS-CoV-2 infection, we examined the association of COVID-19 treatments with 30-day all-cause mortality and factors associated with treatment. Logistic regression with multiple adjustments (e.g., comorbidities, cancer status, baseline COVID-19 severity) was performed. Hydroxychloroquine with any other drug was associated with…
Source: Cancer DiscoveryCategories: Hem/Oncs, Latest HeadlinesTweet-
Hydroxychloroquine + any other drug assoc w/ incr mortality --> Utilization of #COVID19 Tx & clinical outcomes among Pts w/ cancer: A COVID-19 & Cancer Consortium (#CCC19) cohort study [Jul 22, 2020] @DrDonnaRivera et al @CD_AACR https://t.co/enSLlL2TPt #AACRCovid #COVID19nCancer
-
Utilization of #COVID19 treatments & clinical outcomes among patients with cancer: A COVID-19 & Cancer Consortium (#CCC19) cohort study [Jul 22, 2020] @DrDonnaRivera @peters_solange et al @gary_lyman @hemoncwarner @CD_AACR https://t.co/enSLlL2TPt #AACRCovid #COVID19nCancer n=2186 https://t.co/XIvCrlSNGr
-
-
Mashup Score: 0COVID-19 | AACR | Media Advisories - 3 year(s) ago
AACR Calls on Congress to Take Immediate Action Against COVID-19, Protect Patients with Cancer During the Pandemic
Categories: Hem/Oncs, Latest HeadlinesTweet-
AACR Calls on Congress to Take Immediate Action Against COVID-19, Protect Patients with Cancer During the Pandemic [Mar 30, 2020] @AACRFoundation https://t.co/V1AfEWzbEy #COVID19nCancer #COVID19 @COVID19nCCC https://t.co/tCdABMQMLK #AACRcovid
-
-
Mashup Score: 0The Cancer News Daily - 3 year(s) ago
The latest in cancer medicine and translational research by Wafik El-Deiry MDPhD
Source: paper.liCategories: Hem/Oncs, Latest HeadlinesTweet-
The latest The Cancer News Daily! https://t.co/7vCccGaJMF Thanks to @ACS_Research @HemOncToday #cancerpreventionmonth #aacrcovid
-
-
Mashup Score: 0Toni Choueiri on the Effects of Cancer Treatments on Patients Infected With COVID-19 - The ASCO Post - 3 year(s) ago
AACR Virtual Meeting: COVID-19 and Cancer 2021 Advertisement Toni K. Choueiri, MD, of Dana-Farber Cancer Institute, discusses the challenges of delivering optimal cancer treatments in the face of the coronavirus pandemic. Focusing on systemic therapies, he reviews prognostic factors in people with cancer and COVID-19 (Symposium 9). …
Source: ascopost.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Toni K. Choueiri, MD, on the Effects of Cancer Treatments on Patients Infected With COVID-19 https://t.co/3HGlIIjGLa #COVID19 #cancer #oncology @DrChoueiri @DanaFarber #AACRCovid https://t.co/17xk3eRxce
-
-
Mashup Score: 3MSK Experts Share Key Learnings About COVID-19 - 3 year(s) ago
During the AACR COVID-19 and Cancer Meeting, several MSK physicians presented information about providing safe patient care, vaccines, and clinical research.
Categories: Hem/Onc News and Journals, Latest HeadlinesTweet-
At the #AACRCovid and Cancer meeting, MSK experts shared key learnings for how we continued delivering excellent care during #COVID19. @mini_kamboj @jia_luo @SantoshVardhana @DrMiguelPerales @rosslevinemd @AACR https://t.co/z97KBmKXkf
-
-
Mashup Score: 1Anti-CD20 Drugs Tied to Severe COVID in Cancer Patients - 3 year(s) ago
Plus: Active chemo treatment may not be a COVID risk factor
Source: www.medpagetoday.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
CD20-targeting agents such as #Rituxan and #Gazyva were tied to severe #COVID19 in #lymphoma patients, reported Sylvain Lamure, MD, at #AACRCovid. By @icingram. @AACR #LymphSM https://t.co/svZBrRq5u1
-
-
Mashup Score: 5Patients on Active Chemotherapy May Not Be at Increased Risk for COVID-19 Infection - The ASCO Post - 3 year(s) ago
By Jo Cavallo Posted: 2/5/2021 11:31:00 AM Last Updated: 2/8/2021 4:14:46 PM Due to concerns that patients with cancer may be at higher risk for contracting the coronavirus—and may have more severe complications if infected—during the COVID-19 pandemic, hospitals and clinical…
Source: ascopost.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Patients on Active Chemotherapy May Not Be at Increased Risk for COVID-19 Infection https://t.co/egYE23n5ys #COVID19 #cancer #oncology #AACRCovid
-
-
Mashup Score: 0Perales Examines the Impact of COVID-19 on Recipients of Cellular Therapies for Cancer - 3 year(s) ago
February 5, 2021 – Following stem cell transplant or treatment with CAR T-cell therapies, patients with hematologic malignancies and coronavirus disease 2019 tend to have favorable outcomes, especially if they are diagnosed in complete remission and further out from their cell infusion.
Source: OncLiveCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Perales Examines the Impact of COVID-19 on Recipients of Cellular Therapies for Cancer @DrMiguelPerales @sloan_kettering @AACR #AACRCovid #coronavirus #COVID19 https://t.co/u51aYOToIn
-
-
Mashup Score: 0
Shedding of Viable SARS-CoV-2 after Immunosuppressive Therapy for Cancer
Source: PubMedCategories: Hem/Oncs, Latest HeadlinesTweet-
#AACRCovid Study @sloan_kettering + @MountSinaiNYC published @NEJM showed viable virus can persist in HCT pts & CT values helpful in determining contagion risk https://t.co/qxRxX0HTry - interesting preprint shows mutations in M spike > implications for vaccines #TCTM21 https://t.co/Bihuwqzw2H
-
-
Mashup Score: 8Outcomes of patients with hematologic malignancies and COVID-19: a report from the ASH Research Collaborative Data Hub - PubMed - 3 year(s) ago
Coronavirus disease 2019 (COVID-19) is an illness resulting from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that emerged in late 2019. Patients with cancer, and especially those with hematologic malignancies, may be at especially high risk of adverse outcomes, including mortality r …
Source: PubMedCategories: Hem/Oncs, Latest HeadlinesTweet-
Highlights from my @AACR #AACRCovid talk - results of @ASH_hematology @ASHCollab recently published by @bwoodmd & colleagues in @BloodAdvances #COVID19 https://t.co/fnh0uKgDQE https://t.co/tid0HSmFyU
-
Utilization of #COVID19 Tx & clinical outcomes among Pts w/ cancer: A COVID-19 & Cancer Consortium (#CCC19) cohort study [Jul 22, 2020] @DrDonnaRivera et al @CD_AACR https://t.co/enSLlL2TPt #AACRCovid #COVID19nCancer Fig2 Heatmap of selected clinical fx stratified by Tx exposures https://t.co/hFnfgRmCLe